drugset
drugset / Trial / NCT01176201

14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in Man

NCT01176201 ↗

Phase 1 Completed 12 enrolled Abbott Products
RandomizedCrossoverOpen-labelTreatment

Summary

This is an open-label study to determine the ADME (Absorption, Disposition, Metabolism and Excretion) of 14C labeled SLV337 after a single dose of an oral suspension.

Timeline

Start
2010-07
Primary completion
2010-10
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject SLV337 Unknown 400 mg Oral
Subject SLV337 Unknown 1000 mg Oral

Indications

No indication recorded.